136 related articles for article (PubMed ID: 19711353)
21. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.
Wu BX; Zeidan YH; Hannun YA
Biochim Biophys Acta; 2009 Aug; 1791(8):730-9. PubMed ID: 19345744
[TBL] [Abstract][Full Text] [Related]
23. Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.
Baran Y; Bielawski J; Gunduz U; Ogretmen B
J Cancer Res Clin Oncol; 2011 Oct; 137(10):1535-44. PubMed ID: 21833718
[TBL] [Abstract][Full Text] [Related]
24. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
[TBL] [Abstract][Full Text] [Related]
25. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.
Modrak DE; Leon E; Goldenberg DM; Gold DV
Mol Cancer Res; 2009 Jun; 7(6):890-6. PubMed ID: 19531570
[TBL] [Abstract][Full Text] [Related]
26. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL.
Wiesner DA; Kilkus JP; Gottschalk AR; Quintáns J; Dawson G
J Biol Chem; 1997 Apr; 272(15):9868-76. PubMed ID: 9092523
[TBL] [Abstract][Full Text] [Related]
27. p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis.
Hara S; Nakashima S; Kiyono T; Sawada M; Yoshimura S; Iwama T; Banno Y; Shinoda J; Sakai N
Cell Death Differ; 2004 Aug; 11(8):853-61. PubMed ID: 15088070
[TBL] [Abstract][Full Text] [Related]
28. Increased ceramide production sensitizes breast cancer cell response to chemotherapy.
Che J; Huang Y; Xu C; Zhang P
Cancer Chemother Pharmacol; 2017 May; 79(5):933-941. PubMed ID: 28357533
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of acetic acid-induced gastric ulcer formation in rats by glucosylceramide synthase inhibitors.
Nakashita M; Suzuki H; Miura S; Taki T; Uehara K; Mizushima T; Nagata H; Hibi T
Dig Dis Sci; 2013 Feb; 58(2):354-62. PubMed ID: 22918683
[TBL] [Abstract][Full Text] [Related]
30. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.
Wooten LG; Ogretmen B
J Biol Chem; 2005 Aug; 280(32):28867-76. PubMed ID: 15951564
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.
Dupre TV; Doll MA; Shah PP; Sharp CN; Siow D; Megyesi J; Shayman J; Bielawska A; Bielawski J; Beverly LJ; Hernandez-Corbacho M; Clarke CJ; Snider AJ; Schnellmann RG; Obeid LM; Hannun YA; Siskind LJ
J Lipid Res; 2017 Jul; 58(7):1439-1452. PubMed ID: 28490444
[TBL] [Abstract][Full Text] [Related]
32. p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells.
Sawada M; Nakashima S; Kiyono T; Nakagawa M; Yamada J; Yamakawa H; Banno Y; Shinoda J; Nishimura Y; Nozawa Y; Sakai N
Oncogene; 2001 Mar; 20(11):1368-78. PubMed ID: 11313880
[TBL] [Abstract][Full Text] [Related]
33. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
Senchenkov A; Litvak DA; Cabot MC
J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
[TBL] [Abstract][Full Text] [Related]
34. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
Gouazé-Andersson V; Yu JY; Kreitenberg AJ; Bielawska A; Giuliano AE; Cabot MC
Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
[TBL] [Abstract][Full Text] [Related]
35. Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.
Camgoz A; Gencer EB; Ural AU; Avcu F; Baran Y
Leuk Lymphoma; 2011 Aug; 52(8):1574-84. PubMed ID: 21756066
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria.
Blanco-Aparicio C; Pequeño B; Moneo V; Romero L; Leal JF; Velasco J; Fominaya J; Carnero A
Anticancer Drugs; 2005 Oct; 16(9):977-87. PubMed ID: 16162974
[TBL] [Abstract][Full Text] [Related]
37. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
38. Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
Stefanovic M; Tutusaus A; Martinez-Nieto GA; Bárcena C; de Gregorio E; Moutinho C; Barbero-Camps E; Villanueva A; Colell A; Marí M; García-Ruiz C; Fernandez-Checa JC; Morales A
Oncotarget; 2016 Feb; 7(7):8253-67. PubMed ID: 26811497
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M; Apohan E; Baran Y
Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of chemotherapy-triggered glioma cell apoptosis by blockade of arachidonic acid metabolism--the potential role of ceramide accumulation.
Omahen DA
Med Hypotheses; 2011 Nov; 77(5):726-33. PubMed ID: 21862232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]